<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7012450\results\search\disease\results.xml">
  <result pre=": Orthomyxoviruses: Influenza Viruses Assessing antigenic drift and phylogeny of" exact="influenza" post="A (H1N1) pdm09 virus in Kenya using HA1 sub-unit"/>
  <result pre="time in 2017. Herein, we analyzed thirty-eight HA sequences of" exact="influenza" post="A (H1N1) pdm09 strains isolated in Kenya during 2015–2018"/>
  <result pre="A (H1N1) pdm09 viruses that circulated in Kenya during 2015/2016" exact="influenza" post="seasons were antigenic variants of the recommended vaccine strains,"/>
  <result pre="vaccine efficacy. Additionally, data generated point to a swiftly evolving" exact="influenza" post="A (H1N1) pdm09 virus in recent post pandemic era,"/>
  <result pre="with molecular and antigenic analyses, to inform appropriate and timely" exact="influenza" post="vaccine update. Funding This work was supported by the"/>
  <result pre="in the analysis are in the S1 Table. Introduction The" exact="influenza" post="A (H1N1) pdm09 virus emerged in North America in"/>
  <result pre="in March 2009 and rapidly spread worldwide causing the first" exact="influenza" post="pandemic of the 21st Century [1–4]. The virus genome"/>
  <result pre="rare mixture of gene segments from swine, avian and human" exact="influenza" post="viruses [5–8]. The A (H1N1) pdm09 virus was first"/>
  <result pre="endemic in humans, co-circulating with A/H3N2 and B as seasonal" exact="influenza" post="viruses [1, 2, 5, 11]. Influenza virus hemagglutinin (HA)"/>
  <result pre="proteases into HA1 and HA2 domains [16]. Proteolytic cleavage of" exact="influenza" post="virus HA protein is crucial for virus infectivity and"/>
  <result pre="A /H1 viruses [20]. The principal strategy for prevention of" exact="influenza" post="disease is vaccination [21, 22]. However, build-up of amino"/>
  <result pre="of antigenic drift variants [2, 15, 24]. The annually formulated" exact="influenza" post="vaccine comprises HA antigens from A (H3N2), A (H1N1)"/>
  <result pre="strains in the preceding seasons [16, 25]. The effectiveness of" exact="influenza" post="vaccines fluctuate yearly in part due to genetic evolution"/>
  <result pre="Pepitope model may be used to estimate antigenic distance amongst" exact="influenza" post="viruses and thus evaluate vaccine efficacy [26, 27]. Nevertheless,"/>
  <result pre="the vaccine formulation for the first time in the 2017" exact="influenza" post="season [2, 15, 24]. The present study sought to"/>
  <result pre="present study sought to evaluate antigenic and phylogenetic aspects of" exact="influenza" post="A (H1N1) pdm09 viruses circulating in Kenya during 2015/2018"/>
  <result pre="the epitope sites (A-E) within the HA1 protein of Kenyan" exact="influenza" post="A (H1N1) pdm09 strains isolated between 2015 and 2018."/>
  <result pre="range of 32.4–42.1%. The predicted vaccine efficacy of the 2019" exact="influenza" post="A H1N1 pdm09 vaccine strain component (A/Brisbane/02/2018) against Kenyan"/>
  <result pre="2 Estimated vaccine efficacy of recommended WHO vaccine strains against" exact="influenza" post="A (H1N1) pdm09 strains circulating in Kenya during 2015"/>
  <result pre="for Kenyan A/H1N1 pdm09 isolates and vaccine viruses A/California/7/2009 (2015/2016" exact="influenza" post="seasons) and A/Michigan/45/2015 (2017/2018 influenza seasons) is shown in"/>
  <result pre="and vaccine viruses A/California/7/2009 (2015/2016 influenza seasons) and A/Michigan/45/2015 (2017/2018" exact="influenza" post="seasons) is shown in Table 3. The Kenyan 2015/2016"/>
  <result pre="vaccine antigens with WHO reference antisera for 2015/2016 and 2017/2018" exact="influenza" post="seasons. The numbers indicate HAI titers. Reference Antigens Reference"/>
  <result pre="trend [2, 11, 21, 24, 40–44], we have shown that" exact="influenza" post="A (H1N1) pdm09 viruses that circulated in Kenya during"/>
  <result pre="with respect to A/Michigan/45/2015 vaccine virus. This result indicates that" exact="influenza" post="A (H1N1) pdm09 viruses that circulated in Kenya during"/>
  <result pre="amino acid modifications at different HA1 epitope sites of an" exact="influenza" post="virus is antigenically significant as it can give rise"/>
  <result pre="potential N-linked glycosylation sites were conserved in all but one" exact="influenza" post="A (H1N1) pdm09 strains circulating in Kenya during 2015/2018"/>
  <result pre="loss of N-linked glycosylation at HA1 epitope sites can alter" exact="influenza" post="virus antigenic properties [13, 49]. The average dN/dS (ω)"/>
  <result pre="[16]. The predicted vaccine efficacy of A/California/7/2009 vaccine strain against" exact="influenza" post="A (H1N1) pdm09 strains circulating in Kenya during 2015/2016"/>
  <result pre="45]. The estimated vaccine efficacy between A/Michigan/45/2015 vaccine strain and" exact="influenza" post="A (H1N1) pdm09 viruses circulating in Kenya during 2017"/>
  <result pre="yet again supports the WHO February 2019 decision to update" exact="influenza" post="A (H1N1) pdm09 virus vaccine component for northern hemisphere"/>
  <result pre="the A/H1N1 pdm09 strains isolated in Kenya during the 2015/2016" exact="influenza" post="seasons had lower HAI titers (≥2-fold) compared to the"/>
  <result pre="2016 decision to update the A/H1N1 pdm09 strain component of" exact="influenza" post="vaccine from A/California/7/2009 to A/Michigan/45/2015 [53]. Consequently, those viruses"/>
  <result pre="16, 27]. Despite these shortcomings, we have provided evidence that" exact="influenza" post="A (H1N1) pdm09 viruses isolated in Kenya during 2015/2018"/>
  <result pre="with molecular and antigenic analyses, to inform appropriate and timely" exact="influenza" post="vaccine update. Supporting information S1 Table Accession numbers in"/>
  <result pre="FinelliL, ShawM, LindstromS, GartenR, et al.Emergence of a novel swine-origin" exact="influenza" post="A (H1N1) virus in humans. The New England journal"/>
  <result pre="2MonameleCG, NjifonHLM, VernetM-A, NjankouoMR, KenmoeS, YahayaAA, et al.Molecular characterization of" exact="influenza" post="A (H1N1) pdm09 in Cameroon during the 2014–2016 influenza"/>
  <result pre="of influenza A (H1N1) pdm09 in Cameroon during the 2014–2016" exact="influenza" post="seasons. PloS one. 2019;14(1):e021011910.1371/journal.pone.021011930640922 3collab: CDC. Update: swine influenza"/>
  <result pre="2014–2016 influenza seasons. PloS one. 2019;14(1):e021011910.1371/journal.pone.021011930640922 3collab: CDC. Update: swine" exact="influenza" post="A (H1N1) infections—California and Texas, April 2009. MMWR Morbidity"/>
  <result pre="and mortality weekly report. 2009;58(16):43519407739 4collab: CDC. Outbreak of swine-origin" exact="influenza" post="A (H1N1) virus infection-Mexico, March-April 2009. MMWR Morbidity and"/>
  <result pre="AngelovaS, GregoryV, DanielsR, GeorgievaI, McCauleyJ. Antigenic and genetic characterization of" exact="influenza" post="viruses circulating in Bulgaria during the 2015/2016 season. Infection,"/>
  <result pre="PrestiA, et al.Genetic diversity of the haemagglutinin (HA) of human" exact="influenza" post="a (H1N1) virus in montenegro: Focus on its origin"/>
  <result pre="of medical virology. 2016;88(11):1905–13. 10.1002/jmv.2455227088433 7Al HajjarS, McIntoshK. The first" exact="influenza" post="pandemic of the 21st century. Annals of Saudi medicine."/>
  <result pre="et al.Antigenic and genetic characteristics of swine-origin 2009 A (H1N1)" exact="influenza" post="viruses circulating in humans. science. 2009;325(5937):197–201. 10.1126/science.117622519465683 9TabuC, SharifS,"/>
  <result pre="KiokoJ, NziokaC, MuthokaP, et al.Introduction and transmission of 2009 pandemic" exact="influenza" post="A (H1N1) Virus-Kenya, June-July 2009. Morbidity and Mortality Weekly"/>
  <result pre="SymekherS, OtienoM, MaganaJ, OpotB, BulimoW. Whole genome characterization of human" exact="influenza" post="A (H1N1) pdm09 viruses isolated from Kenya during the"/>
  <result pre="HuangC-T, ChangK-Y, HuangY-C, GongY-N. Clinical characteristics of patients with laboratory-confirmed" exact="influenza" post="A (H1N1) pdm09 during the 2013/2014 and 2015/2016 clade"/>
  <result pre="SuntronwongN, ThongmeeT, et al.Evolution of the neuraminidase gene of seasonal" exact="influenza" post="A and B viruses in Thailand between 2010 and"/>
  <result pre="et al.Genetic diversity of HA1 domain of heammaglutinin gene of" exact="influenza" post="A (H1N1) pdm09 in Tunisia. Virology journal. 2013;10(1):150.23679923 14EbranatiE,"/>
  <result pre="BubbaL, et al.Reconstruction of the evolutionary dynamics of A (H3N2)" exact="influenza" post="viruses circulating in Italy from 2004 to 2012. PloS"/>
  <result pre="SoniP, TakenagaT, KawakamiC, TakashitaE, et al.Diversity of antigenic mutants of" exact="influenza" post="A (H1N1) pdm09 virus escaped from human monoclonal antibodies."/>
  <result pre="VichiwattanaP, KorkongS, KlinfuengS, VongpunsawadS, et al.Assessing antigenic drift of seasonal" exact="influenza" post="A (H3N2) and A (H1N1) pdm09 viruses. PloS one."/>
  <result pre="2015;10(10):e013995810.1371/journal.pone.013995826440103 17Böttcher-FriebertshäuserE, FreuerC, SielaffF, SchmidtS, EickmannM, UhlendorffJ, et al.Cleavage of" exact="influenza" post="virus hemagglutinin by airway proteases TMPRSS2 and HAT differs"/>
  <result pre="et al.Epitope mapping of the hemagglutinin molecule of A/(H1N1) pdm09" exact="influenza" post="virus by using monoclonal antibody escape mutants. Journal of"/>
  <result pre="10.1128/JVI.01381-1425122788 19CatonAJ, BrownleeGG, YewdellJW, GerhardW. The antigenic structure of the" exact="influenza" post="virus A/PR/8/34 hemagglutinin (H1 subtype). Cell. 1982;31(2):417–27.6186384 20DeemMW, PanK."/>
  <result pre="subtype). Cell. 1982;31(2):417–27.6186384 20DeemMW, PanK. The epitope regions of H1-subtype" exact="influenza" post="A, with application to vaccine efficacy. Protein Engineering, Design"/>
  <result pre="21FriedmanN, DroriY, PandoR, Glatman-FreedmanA, SeftyH, BassalR, et al.A (H1N1) pdm09" exact="influenza" post="infection: vaccine inefficiency. Oncotarget. 2017;8(20):3285610.18632/oncotarget.1645928415629 22Puig-BarberàJ, Guglieri-LópezB, Tortajada-GirbésM, López-LabradorFX,"/>
  <result pre="Oncotarget. 2017;8(20):3285610.18632/oncotarget.1645928415629 22Puig-BarberàJ, Guglieri-LópezB, Tortajada-GirbésM, López-LabradorFX, Carballido-FernándezM, Mollar-MaseresJ, et al.Low" exact="influenza" post="vaccine effectiveness and the effect of previous vaccination in"/>
  <result pre="in patients 60 years old or older during the 2015/2016" exact="influenza" post="season. Vaccine. 2017;35(52):7331–8. 10.1016/j.vaccine.2017.10.10029128380 23UnderwoodPA, SkehelJ, WileyD. Receptor-binding characteristics"/>
  <result pre="SkehelJ, WileyD. Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of" exact="influenza" post="virus. Journal of virology. 1987;61(1):206–8. 3783824 24WHO. Recommended composition"/>
  <result pre="virus. Journal of virology. 1987;61(1):206–8. 3783824 24WHO. Recommended composition of" exact="influenza" post="virus vaccines for use in the 2018 southern hemisphere"/>
  <result pre="influenza virus vaccines for use in the 2018 southern hemisphere" exact="influenza" post="season 2017. Available from: https://www.who.int/influenza/vaccines/virus/recommendations/201709_recommendation.pdf?ua=1. 25SuwannakarnK, ChieochansinT, ThongmeeC, MakkochJ,"/>
  <result pre="PraianantathavornK, TheamboonlersA, et al.Molecular evolution of human H1N1 and H3N2" exact="influenza" post="A virus in Thailand, 2006–2009. PLoS One. 2010;5(3):e971710.1371/journal.pone.000971720300536 26LiX,"/>
  <result pre="Engineering, Design and Selection. 2016;29(8):309–15. 10.1093/protein/gzw01727313229 27GuptaV, EarlDJ, DeemMW. Quantifying" exact="influenza" post="vaccine efficacy and antigenic distance. Vaccine. 2006;24(18):3881–8. 10.1016/j.vaccine.2006.01.01016460844 28WHO."/>
  <result pre="method for full genome sequencing of multiple subtypes of human" exact="influenza" post="A viruses. Journal of Clinical Virology. 2015;68:43–8. 10.1016/j.jcv.2015.04.01926071334 32BioSoftH."/>
  <result pre="sites in human proteins. 2004. 2017. 40WHO. Recommended composition of" exact="influenza" post="virus vaccines for use in the 2016 southern hemisphere"/>
  <result pre="influenza virus vaccines for use in the 2016 southern hemisphere" exact="influenza" post="season 2015 [cited 2019 2nd April]. Available from: https://www.who.int/influenza/vaccines/virus/recommendations/201509_recommendation.pdf?ua=1."/>
  <result pre="2019 2nd April]. Available from: https://www.who.int/influenza/vaccines/virus/recommendations/201509_recommendation.pdf?ua=1. 41WHO. Recommended composition of" exact="influenza" post="virus vaccines for use in the 2017 southern hemisphere"/>
  <result pre="influenza virus vaccines for use in the 2017 southern hemisphere" exact="influenza" post="season 2016 [cited 2019 2nd April]. Available from: https://www.who.int/influenza/vaccines/virus/recommendations/2017_south/en/."/>
  <result pre="De SerresG, et al.Interim estimates of 2015/16 vaccine effectiveness against" exact="influenza" post="A (H1N1) pdm09, Canada, February 2016. Eurosurveillance. 2016;21(11). 43ECDC."/>
  <result pre="RijalP, SchimanskiL, PowellTJ, LinT-Y, McCauleyJW, et al.Focused antibody response to" exact="influenza" post="linked to antigenic drift. The Journal of clinical investigation."/>
  <result pre="et al.Identification of amino acid substitutions supporting antigenic change of" exact="influenza" post="A (H1N1) pdm09 viruses. Journal of virology. 2015;89(7):3763–75. 10.1128/JVI.02962-1425609810"/>
  <result pre="2015;89(7):3763–75. 10.1128/JVI.02962-1425609810 47WilsonIA, CoxNJ. Structural basis of immune recognition of" exact="influenza" post="virus hemagglutinin. Annual review of immunology. 1990;8(1):737–87. 48MohebbiA, FotouhiF,"/>
  <result pre="FarahmandB, MohebbiR. Molecular epidemiology of the hemagglutinin gene of prevalent" exact="influenza" post="virus A/H1N1/pdm09 among patient in Iran. Virus research. 2019;259:38–45."/>
  <result pre="AbdelwhabE-SM, SlaninaH, HusseinMA, KuznetsovaI, SchüttlerCG, et al.Phylogenetic analysis of human" exact="influenza" post="A/H3N2 viruses isolated in 2015 in Germany indicates significant"/>
  <result pre="DickinsonJA, OlshaR, et al.Interim estimates of 2018/19 vaccine effectiveness against" exact="influenza" post="A (H1N1) pdm09, Canada, January 2019. Eurosurveillance. 2019;24(4). 51WHO."/>
  <result pre="pdm09, Canada, January 2019. Eurosurveillance. 2019;24(4). 51WHO. Recommended composition of" exact="influenza" post="virus vaccines for use in the 2019–2020 northern hemisphere"/>
  <result pre="influenza virus vaccines for use in the 2019–2020 northern hemisphere" exact="influenza" post="season 2019 [cited 2019 2nd April]. Available from: https://www.who.int/influenza/vaccines/virus/recommendations/201902_recommendation.pdf?ua=1."/>
  <result pre="2019 2nd April]. Available from: https://www.who.int/influenza/vaccines/virus/recommendations/201902_recommendation.pdf?ua=1. 52WHO. Recommended composition of" exact="influenza" post="virus vaccines for use in the 2016 southern hemisphere"/>
  <result pre="influenza virus vaccines for use in the 2016 southern hemisphere" exact="influenza" post="season. 2015. 53WHO. Recommended composition of influenza virus vaccines"/>
  <result pre="2016 southern hemisphere influenza season. 2015. 53WHO. Recommended composition of" exact="influenza" post="virus vaccines for use in the 2017 southern hemisphere"/>
  <result pre="influenza virus vaccines for use in the 2017 southern hemisphere" exact="influenza" post="season 2016. Available from: https://www.who.int/influenza/vaccines/virus/recommendations/201609_recommendation.pdf?ua=1. 54ClarkAM, DeDiegoML, AndersonCS, WangJ,"/>
  <result pre="YangH, NogalesA, et al.Antigenicity of the 2015–2016 seasonal H1N1 human" exact="influenza" post="virus HA and NA proteins. PLoS One. 2017;12(11):e018826710.1371/journal.pone.018826729145498"/>
 </snippets>
</snippetsTree>
